Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Eisai
Eisai
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Regulatory
FDA grants landmark approval for Alzheimer’s treatment
LEQEMBI is the first and only approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional decline in adults with Alzheimer’s disease
Regulatory
AbbVie and Eisai launch online Humira support tool service
The free-of-charge service assists patients on Humira therapy by delivering support tools to their home or other requested location
Finance
Eisai and Fuji Yakuhin sign ASEAN distribution agreement for gout therapy
Hyperuricemia is known to be associated with various diseases in the urinary system, endocrine system, metabolic system, cardio-cerebrovascular system etc., including gout
Research & Development
Eisai and Biogen announce Phase IV Alzheimer's study design
The companies will be evaluating the long-term effectiveness and safety data of Biogen's Alzheimer's therapy, Aduhelm
Regulatory
Eisai and Merck combination cancer therapy approved by FDA
The approval for this population is based on results from a Phase III Study 309/KEYNOTE-775 trial
Research & Development
Eisai makes major investments in drug creation
Platform will be established to combine Eisaid know-how with external big data and genomic data for drug innovation in neurology and oncology
Ingredients
Therapeutics: lemborexant for sleep disorders
About a third of adults suffer from the symptoms of insomnia, such as difficulty falling asleep, staying asleep or both
Subscribe now